A prospective observational multicentric pan India study of lenvatinib in radio-iodine refractory advanced differentiated thyroid cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e18106
Abstract: e18106Background: Management of advanced differentiated thyroid cancer refractory to radio-iodine (RAI) has taken a new turn with the results of SELECT trial. Physicians are learning to use lenvati... read more here.
Keywords: advanced differentiated; differentiated thyroid; radio iodine; thyroid cancer ... See more keywords